Analysis Shows Feasibility Studies Could be Conducted in Half the Time - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Analysis Shows Feasibility Studies Could be Conducted in Half the Time

Source: Applied Clinical Trials

Last September, inVentiv Clinical Trial Recruitment Solutions (iCTRS), announced its strategic partnership with ViS Research to address the challenges of clinical trial site evaluation. Four months later, the company has released analysis that could prove potential savings in the ViS platform for clinical trial feasibility studies. iCTRS took data from 100 feasibility studies conducted by inVentiv and analyzed the time required to perform each of the individual tasks involved in such studies. iCTRS then looked at how much time the application of ViS technology could save for each task. Cumulatively, the efficiencies offered by ViS cut the total feasibility study hours by 54% -- while delivering better quality.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here